Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Estimation and testing problems in auditory neuroscience via clustering.

Hwang Y, Wright S, Hanlon BM.

Biometrics. 2017 Jan 18. doi: 10.1111/biom.12652. [Epub ahead of print]

PMID:
28099996
2.

Evolvix BEST Names for semantic reproducibility across code2brain interfaces.

Loewe L, Scheuer KS, Keel SA, Vyas V, Liblit B, Hanlon B, Ferris MC, Yin J, Dutra I, Pietsch A, Javid CG, Moog CL, Meyer J, Dresel J, McLoone B, Loberger S, Movaghar A, Gilchrist-Scott M, Sabri Y, Sescleifer D, Pereda-Zorrilla I, Zietlow A, Smith R, Pietenpol S, Goldfinger J, Atzen SL, Freiberg E, Waters NP, Nusbaum C, Nolan E, Hotz A, Kliman RM, Mentewab A, Fregien N, Loewe M.

Ann N Y Acad Sci. 2017 Jan;1387(1):124-144. doi: 10.1111/nyas.13192. Epub 2016 Dec 5.

3.

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.

Graham HT, Rotroff DM, Marvel SW, Buse JB, Havener TM, Wilson AG, Wagner MJ, Motsinger-Reif AA; ACCORD/ACCORDion Investigators..

Front Genet. 2016 Aug 17;7:138. eCollection 2016.

4.

Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer.

Eng KH, Hanlon BM, Bradley WH, Szender JB.

Gynecol Oncol. 2015 Nov;139(2):228-35. doi: 10.1016/j.ygyno.2015.09.011. Epub 2015 Sep 14.

5.

Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.

Espeland MA, Probstfield J, Hire D, Redmon JB, Evans GW, Coday M, Lewis CE, Johnson KC, Wilmoth S, Bahnson J, Dulin MF, Green JB, Knowler WC, Kitabchi A, Murillo AL, Osei K, Rehman SU, Cushman WC; Look AHEAD Research Group.; ACCORD Study Group..

Am J Hypertens. 2015 Aug;28(8):995-1009. doi: 10.1093/ajh/hpu292. Epub 2015 Feb 9.

6.

Spatio-temporal in vivo recording of dCREB2 dynamics in Drosophila long-term memory processing.

Zhang J, Tanenhaus AK, Davis JC, Hanlon BM, Yin JC.

Neurobiol Learn Mem. 2015 Feb;118:80-8. doi: 10.1016/j.nlm.2014.11.010. Epub 2014 Nov 22.

7.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.

Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators..

Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0. Erratum in: Lancet. 2016 Sep 24;388(10051):1280.

PMID:
24881993
8.

Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.

Amin SB, Yip WK, Minvielle S, Broyl A, Li Y, Hanlon B, Swanson D, Shah PK, Moreau P, van der Holt B, van Duin M, Magrangeas F, Pieter Sonneveld P, Anderson KC, Li C, Avet-Loiseau H, Munshi NC.

Leukemia. 2014 Nov;28(11):2229-34. doi: 10.1038/leu.2014.140. Epub 2014 Apr 15.

9.

Discrete mixture modeling to address genetic heterogeneity in time-to-event regression.

Eng KH, Hanlon BM.

Bioinformatics. 2014 Jun 15;30(12):1690-7. doi: 10.1093/bioinformatics/btu065. Epub 2014 Feb 14.

10.

Hierarchical model for evaluating pyrantel efficacy against strongyle parasites in horses.

Nielsen MK, Vidyashankar AN, Hanlon BM, Diao G, Petersen SL, Kaplan RM.

Vet Parasitol. 2013 Nov 8;197(3-4):614-22. doi: 10.1016/j.vetpar.2013.04.036. Epub 2013 Apr 26.

PMID:
23680542
11.

Determinants of weight gain in the action to control cardiovascular risk in diabetes trial.

Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC; ACCORD Study Group..

Diabetes Care. 2013 Aug;36(8):2162-8. doi: 10.2337/dc12-1391. Epub 2013 Feb 14.

12.

Penalized likelihood phenotyping: unifying voxelwise analyses and multi-voxel pattern analyses in neuroimaging: penalized likelihood phenotyping.

Adluru N, Hanlon BM, Lutz A, Lainhart JE, Alexander AL, Davidson RJ.

Neuroinformatics. 2013 Apr;11(2):227-47. doi: 10.1007/s12021-012-9175-9.

13.

Neural response to pictures of food after exercise in normal-weight and obese women.

Hanlon B, Larson MJ, Bailey BW, LeCheminant JD.

Med Sci Sports Exerc. 2012 Oct;44(10):1864-70. doi: 10.1249/MSS.0b013e31825cade5.

PMID:
22617393
14.

Statistical and biological considerations in evaluating drug efficacy in equine strongyle parasites using fecal egg count data.

Vidyashankar AN, Hanlon BM, Kaplan RM.

Vet Parasitol. 2012 Apr 19;185(1):45-56. doi: 10.1016/j.vetpar.2011.10.011. Epub 2011 Oct 18. Review.

PMID:
22119386
15.

A motif-independent metric for DNA sequence specificity.

Pinello L, Lo Bosco G, Hanlon B, Yuan GC.

BMC Bioinformatics. 2011 Oct 21;12:408. doi: 10.1186/1471-2105-12-408.

16.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

ACCORD Study Group., Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT.

N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.

17.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group..

Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Erratum in: Lancet. 2010 Oct 30;376(9751):1466.

18.

Effects of medical therapies on retinopathy progression in type 2 diabetes.

ACCORD Study Group.; ACCORD Eye Study Group., Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ.

N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. N Engl J Med. 2012 Dec 20;367(25):2458.

19.

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group., Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP.

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748.

20.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group., Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

Supplemental Content

Loading ...
Support Center